TABLE 2.
IFN-inducing capacities of VSV field isolates and plaque-derived populationsa
| Virus type or designation | No. of samples | IFN yield (U/107 cells) (mean ± SD) | Range | Fold difference |
|---|---|---|---|---|
| VSV-IN isolates (first-passage populations) | 32 | 451 ± 694 | 50–2810 | 56 |
| VSV-NJ isolates (first-passage populations) | 34 | 4,429 ± 7,688 | 350–45,000 | 129 |
| VSV-IN no. 11 (plaque-derived subpopulations) | 27 | 4,680 ± 3,560 | 160–14,310 | 89 |
| VSV-NJ Lab no. 71 (vesicle plaque-derived subpopulations) | 77 | 858 ± 404 | 310–2,790 | 9 |
| VSV-IN Lab no. 22 (plaque-derived subpopulations) | ||||
| With no. 22-20 | 36 | 940 ± 5,165 | 15–31,000 | 2,100 |
| Without no. 22-20 | 35 | 79 ± 33 | 15–168 | 11 |